Surevest’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$45K Buy
99
+5
+5% +$2.39K 0.01% 192
2022
Q2
$45K Hold
94
0.01% 207
2022
Q1
$46K Hold
94
0.01% 190
2021
Q4
$44K Buy
+94
New +$39.5K 0.01% 196

Other funds holding ELV

Surevest's ELV Position: Q3 2022 in Review

Surevest increased its Elevance Health (ELV) stake by 5.3% in Q3 2022, buying an estimated $2.39K and bringing the position to 99 shares worth $45K. The position accounts for 0.01% of the portfolio, ranked #192.

Surevest first reported a position in ELV in Q4 2021 and has held it in 4 quarters since. The position peaked at $46K in Q1 2022. 1,445 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • Surevest held 99 shares of Elevance Health worth $45K as of Q3 2022.
  • Surevest bought 5 Elevance Health shares in Q3 2022, an estimated $2.39K.
  • Elevance Health made up 0.01% of Surevest's portfolio in Q3 2022, its #192 holding.
  • Surevest first reported a position in Elevance Health in Q4 2021 and has held it in 4 quarters since.
  • Surevest's Elevance Health position peaked at $46K in Q1 2022.
  • 1,445 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.